163 related articles for article (PubMed ID: 36556179)
1. Predictive Risk Factors of Nonalcoholic Fatty Liver Disease in a Lean Chinese Population.
Liu L; Shi X; Gao J; Xu C; Liu X
J Pers Med; 2022 Nov; 12(12):. PubMed ID: 36556179
[TBL] [Abstract][Full Text] [Related]
2. Development and validation of a nomogram for predicting nonalcoholic fatty liver disease in the non-obese Chinese population.
Wang J; Tang Y; Peng K; Liu H; Xu J
Am J Transl Res; 2020; 12(10):6149-6159. PubMed ID: 33194020
[TBL] [Abstract][Full Text] [Related]
3. Development and application of a novel model to predict the risk of non-alcoholic fatty liver disease among lean pre-diabetics with normal blood lipid levels.
Zhu W; Shi P; Fu J; Liang A; Zheng T; Wu X; Yuan S
Lipids Health Dis; 2022 Dec; 21(1):149. PubMed ID: 36585668
[TBL] [Abstract][Full Text] [Related]
4. A clinical and laboratory-based nomogram for predicting nonalcoholic fatty liver disease in non-diabetic adults: a cross-sectional study.
Qian Y; Sun B; Zhang Y; Zhang M; Jiao X; Lai L; Yang W
Ann Palliat Med; 2022 Jul; 11(7):2349-2359. PubMed ID: 35542976
[TBL] [Abstract][Full Text] [Related]
5. A Prediction Model of the Incidence of Nonalcoholic Fatty Liver Disease With Visceral Fatty Obesity: A General Population-Based Study.
Zhou Y; Chai X; Guo T; Pu Y; Zeng M; Zhong A; Yang G; Cai J
Front Public Health; 2022; 10():895045. PubMed ID: 35812496
[TBL] [Abstract][Full Text] [Related]
6. A Prediction Model Based on Noninvasive Indicators to Predict the 8-Year Incidence of Type 2 Diabetes in Patients with Nonalcoholic Fatty Liver Disease: A Population-Based Retrospective Cohort Study.
Cai X; Zhu Q; Cao Y; Liu S; Wang M; Wu T; Hong J; Ahmat A; Aierken X; Li N
Biomed Res Int; 2021; 2021():5527460. PubMed ID: 34095297
[TBL] [Abstract][Full Text] [Related]
7. LASSO-derived model for the prediction of lean-non-alcoholic fatty liver disease in examinees attending a routine health check-up.
Hsu CL; Wu PC; Wu FZ; Yu HC
Ann Med; 2024 Dec; 56(1):2317348. PubMed ID: 38364216
[TBL] [Abstract][Full Text] [Related]
8. Role of Fatty Liver Index and Metabolic Factors in the Prediction of Nonalcoholic Fatty Liver Disease in a Lean Population Receiving Health Checkup.
Hsu CL; Wu FZ; Lin KH; Chen YH; Wu PC; Chen YH; Chen CS; Wang WH; Mar GY; Yu HC
Clin Transl Gastroenterol; 2019 May; 10(5):1-8. PubMed ID: 31082856
[TBL] [Abstract][Full Text] [Related]
9. Whole-Exome Sequencing Identifies a Variant in Phosphatidylethanolamine N-Methyltransferase Gene to be Associated With Lean-Nonalcoholic Fatty Liver Disease.
Bale G; Vishnubhotla RV; Mitnala S; Sharma M; Padaki RN; Pawar SC; Duvvur RN
J Clin Exp Hepatol; 2019; 9(5):561-568. PubMed ID: 31695245
[TBL] [Abstract][Full Text] [Related]
10. Development and Validation of a Risk Prediction Model for NAFLD: A Study Based on a Physical Examination Population.
Yang C; Du T; Zhao Y; Qian Y; Tang J; Li X; Ma L
Diabetes Metab Syndr Obes; 2024; 17():143-155. PubMed ID: 38222035
[TBL] [Abstract][Full Text] [Related]
11. Clinical spectrum transition and prediction model of nonalcoholic fatty liver disease in children with obesity.
Zhou X; Lin X; Chen J; Pu J; Wu W; Wu Z; Lin H; Huang K; Zhang L; Dai Y; Ni Y; Dong G; Fu J
Front Endocrinol (Lausanne); 2022; 13():986841. PubMed ID: 36120457
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of a clinical and laboratory-based nomogram to predict nonalcoholic fatty liver disease.
Cen C; Wang W; Yu S; Tang X; Liu J; Liu Y; Zhou L; Yu J; Zheng S
Hepatol Int; 2020 Sep; 14(5):808-816. PubMed ID: 32572817
[TBL] [Abstract][Full Text] [Related]
13. Nomogram for predicting the risk of nonalcoholic fatty liver disease in older adults in Qingdao, China: A cross-sectional study.
Wang Z; Cui J; Li X; Gao R; Feng E; Luo G; Guo B; Wu H; Sun Y; Sun J
Asia Pac J Clin Nutr; 2024 Mar; 33(1):83-93. PubMed ID: 38494690
[TBL] [Abstract][Full Text] [Related]
14. Establishment of a Risk Prediction Model for Non-alcoholic Fatty Liver Disease in Type 2 Diabetes.
Zhang Y; Shi R; Yu L; Ji L; Li M; Hu F
Diabetes Ther; 2020 Sep; 11(9):2057-2073. PubMed ID: 32725485
[TBL] [Abstract][Full Text] [Related]
15. Higher serum uric acid to HDL-cholesterol ratio is associated with onset of non-alcoholic fatty liver disease in a non-obese Chinese population with normal blood lipid levels.
Zhu W; Liang A; Shi P; Yuan S; Zhu Y; Fu J; Zheng T; Wen Z; Wu X
BMC Gastroenterol; 2022 Apr; 22(1):196. PubMed ID: 35448944
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of a nomogram for nonalcoholic fatty liver disease in Western Xinjiang, China.
Zheng S; Li D; Shi Z; Yang Y; Li L; Chen P; A Bulimiti X; Li F
Eur J Gastroenterol Hepatol; 2024 Jun; ():. PubMed ID: 38916218
[TBL] [Abstract][Full Text] [Related]
17. Lean-non-alcoholic fatty liver disease increases risk for metabolic disorders in a normal weight Chinese population.
Feng RN; Du SS; Wang C; Li YC; Liu LY; Guo FC; Sun CH
World J Gastroenterol; 2014 Dec; 20(47):17932-40. PubMed ID: 25548491
[TBL] [Abstract][Full Text] [Related]
18. A Nomogram Model Based on Noninvasive Bioindicators to Predict 3-Year Risk of Nonalcoholic Fatty Liver in Nonobese Mainland Chinese: A Prospective Cohort Study.
Cai X; Aierken X; Ahmat A; Cao Y; Zhu Q; Wu T; Li N
Biomed Res Int; 2020; 2020():8852198. PubMed ID: 33204721
[TBL] [Abstract][Full Text] [Related]
19. Characterization of lean patients with nonalcoholic fatty liver disease: potential role of high hemoglobin levels.
Akyuz U; Yesil A; Yilmaz Y
Scand J Gastroenterol; 2015 Mar; 50(3):341-6. PubMed ID: 25540973
[TBL] [Abstract][Full Text] [Related]
20. Development and validation of an online dynamic nomogram based on the atherogenic index of plasma to screen nonalcoholic fatty liver disease.
Peng H; Zhang J; Huang X; Xu M; Huang J; Wu Y; Peng XE
Lipids Health Dis; 2023 Mar; 22(1):44. PubMed ID: 36991386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
